MindBio Therapeutics Corp. (CSE:MBIO)

Canada flag Canada · Delayed Price · Currency is CAD
0.0100
+0.0050 (100.00%)
Jun 3, 2025, 4:00 PM EDT
-80.00%
Market Cap 5.46M
Revenue (ttm) -565.34K
Net Income (ttm) -1.46M
Shares Out 546.20M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,981,303
Average Volume 389,610
Open 0.0100
Previous Close 0.0050
Day's Range 0.0100 - 0.0150
52-Week Range 0.0050 - 0.0550
Beta 1.01
RSI 53.04
Earnings Date May 13, 2025

About MindBio Therapeutics

MindBio Therapeutics Corp., together with its subsidiaries, operates as a clinical stage drug development company in Australasia. The company engages in researching, developing, and testing microdosing of psychedelic substances as a potential treatment for the management of various mental health conditions, such as depression, anxiety, chronic pain, cognitive impairment, post-traumatic stress disorder, panic disorder, and opiate addictions. It also establishes and executes research protocols through formal clinical trials that are facilitated v... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol MBIO
Full Company Profile

Financial Performance

Financial numbers in AUD Financial Statements

News

There is no news available yet.